In the 2000s, Rubenstein et al. and Kunkel et al. demonstrated that anti-VEGF treatment of orthotopic brain tumors in immunodeficient mice led to the increased infiltration and co-option of the host vasculature, despite a decrease in tumor vascularity and proliferation [40,41]. This evidence concerns the gene VEGFA and neoplasm.